{"nct_id":"NCT01290900","title":"A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2011-05","primary_completion_date_type":"ACTUAL","completion_date":"2011-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["PFE"]}